Looking back on the symposium ‘Are all QALYs equal?'

On September 16 2019, the Erasmus School of Health Policy & Management organised the symposium ‘Are all QALYs equal? Past, present and future of equity weighting.’

After Werner Brouwer (Erasmus School of Health Policy & Management) opened the symposium, Jan van Busschbach (Erasmus MC and member of the Adviescommissie Pakket), Jan Abel Olsen (Universiteit van Tromsø, Noorwegen), Sylvia Vijgen (Zorginstituut Nederland) and Vivian Reckers-Droog (Erasmus School of Health Policy & Management) addressed the issue of ‘priority setting in the allocation of healthcare resources’. This issue concerns decisions regarding the content of the basic health insurance package and the equity considerations that are considered relevant in these decisions.

Are you interested in the presentations that were given during the symposium? Download them here:

Link to presentation Jan van Busschbach
Link to presentation Jan Abel Olsen
Link to presentation Sylvia Vijgen
Link to presentation Vivian Reckers-Droog
This symposium was linked to the Broader Societal Benefits research program that is financially supported by Pfizer, GlaxoSmithKline, AbbVie, Amgen, and AstraZeneca.